{{knowledge objective
|Identifiant=OIC-224-16-B
|Item_parent=Hypertension in adults and children
|Item_parent_short=Hypertension in adults and children
|Rank=B
|Title=Knowing the specific clinical situations that can guide the choice of anti-hypertensive treatment
|Description=None
|Section=Management
|Contributors=
|Order=16}}
The choice of antihypertensive active substance may be guided by the patient's co-morbidities:
{| class="wikitable"
|'''Comorbidities'''
|'''Preferred molecules''''
|-
|Patient [[Diabetes mellitus types 1 and 2 in children and adults. Complications|diabetic]] from the stage of microalbuminuria or [[Chronic renal failure in adults and children|renal failure]].
|[[Drugs of the renin-angiotensin system: mechanisms of action, indications, side effects, drug interactions, monitoring procedures and main causes of failure 2C-330-PC-A04|IEC or ARA2]]
|-
|Patients with chronic renal insufficiency in adults and children|renal insufficiency]] or proteinuria and nephrotic syndrome in adults and children|proteinuria]].
|[[Drugs of the renin-angiotensin system: mechanisms of action, indications, side effects, drug interactions, monitoring and main causes of failure 2C-330-PC-A04|IEC or ARA2]]
|-
|[[Cerebrovascular accident|Cerebrovascular accident]] post-stroke patient
|[[Diuretics/know the mechanisms of action, indications, side effects drug interactions, monitoring procedures and main causes of failure 2C-330-PC-A02|Thiazide diuretics]]
[[Drugs of the renin-angiotensin system: mechanisms of action, indications, side effects, drug interactions, monitoring and main causes of failure 2C-330-PC-A04|IEC or ARA2]]

[Calcium channel blockers|Calcium channel blockers
|-
|Patient [[Coronary artery disease and acute coronary syndromes 2C-231-DP-A16|coronary artery disease]]
|[[Drugs of the renin-angiotensin system: mechanisms of action, indications, side effects, drug interactions, monitoring procedures and main causes of failure 2C-330-PC-A04|IEC or ARA2]]
[[Beta-blockers/know the mechanisms of action, indications, side effects, drug interactions, monitoring and main causes of failure 2C-330-PC-A03|Beta-blockers]]
|-
|Patient [[Heart failure in adults|heart failure patients]]
|[[Drugs of the renin-angiotensin system: mechanisms of action, indications, side effects, drug interactions, monitoring procedures and main causes of failure 2C-330-PC-A04|IEC or ARA2]]
[[Beta-blockers/know the mechanisms of action, indications, side effects, drug interactions, monitoring and main causes of failure 2C-330-PC-A03|Beta-blockers]]

[[Diuretics/know the mechanisms of action, indications, side effects drug interactions, monitoring procedures and main causes of failure 2C-330-PC-A02|Diuretics]]
|}